Day: May 12, 2026

Hong Kong Corporate News

Yuzhou Group April 2026 Unaudited Operating Figures: Contracted Sales Amounts and Sales Areas Announced

Minichart

May 12, 2026

Yuzhou Group Holdings Announces April 2026 Unaudited Operati...

Continue Reading 0

Hong Kong Corporate News

CHK Oil Limited Extends MOU Period with Aral Petroleum Capital LLP for Oilfield Cooperation Until November 2026

Minichart

May 12, 2026

CHK Oil Limited Extends MOU with Aral Petroleum Capital LLP ...

Continue Reading 0

Hong Kong Corporate News

WellCell Holdings Announces Change in Use of IPO Proceeds to Fund ICT Projects and Repay Bank Borrowings

Minichart

May 12, 2026

WellCell Holdings Announces Change in Use of IPO Proceeds – ...

Continue Reading 0

Hong Kong Corporate News

Zhihu Inc. Announces Board Meeting and Q1 2026 Earnings Call Scheduled for June 3, 2026 1

Minichart

May 12, 2026

Zhihu Inc. Announces Upcoming Board Meeting and Q1 2026 Resu...

Continue Reading 0

Hong Kong Corporate News

China Traditional Chinese Medicine Holdings Announces Approval of Ancient Classic Formula Granules for Market by China National Medical Products Administration 12

Minichart

May 12, 2026

China Traditional Chinese Medicine Holdings: Granule Approva...

Continue Reading 0

Hong Kong Corporate News

Chuang’s Consortium Announces Reduced Loss for Year Ended 31 March 2026, Estimates HK$345–390 Million Loss Compared to Previous HK$591 Million 12

Minichart

May 12, 2026

Chuang’s Consortium International Limited Announces Signific...

Continue Reading 0

Hong Kong Corporate News

Chuang’s China Investments Announces Significant Reduction in Annual Loss for Year Ended 31 March 2026 1

Minichart

May 12, 2026

Chuang’s China Investments Limited Announces Significant Red...

Continue Reading 0

Hong Kong Corporate News

CSPC Pharmaceutical’s SYS6010 Granted Breakthrough Therapy Designation in China for Advanced Esophageal Squamous Cell Carcinoma 1

Minichart

May 12, 2026

CSPC Pharmaceutical Group Granted Breakthrough Therapy Desig...

Continue Reading 0

Hong Kong Corporate News

Suzhou Ribo Life Science Submits Phase 2b Clinical Trial Application for Vortosiran in Venous Thromboembolism to EMA 1

Minichart

May 12, 2026

Suzhou Ribo Life Science Co., Ltd. Announces Phase 2b Clinic...

Continue Reading 0

Hong Kong Corporate News

CIFI Holdings Announces April 2026 Unaudited Contracted Sales and Operating Statistics

Minichart

May 12, 2026

CIFI Holdings Announces April 2026 Unaudited Operating Stati...

Continue Reading 0